JP Stock MarketDetailed Quotes

4552 JCR Pharmaceuticals

Watchlist
  • 535
  • 00.00%
20min DelayMarket Closed Aug 9 15:00 JST
69.38BMarket Cap12.18P/E (Static)

JCR Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JCR Pharmaceuticals Earnings Date

Currency: JPY

Period

Q1 FY2025 Earnings

Jul 30, 2024

Revenue(YoY)

8.15B

-24.64%
EPS(YoY)

1.61

-87.47%
Analyst Rating

Buy

Jul 30, 2024

JCR Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 11.300B--
--2025/Q2-- / 11.300B--
Jul 30, 20242025/Q18.145B / 11.300B--
May 10, 20242024/Q49.153B / 12.382B--
Jan 26, 20242024/Q39.446B / 13.000B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 11.300B--
--2025/Q2-- / 11.300B--
Jul 30, 20242025/Q18.145B / 11.300B--
May 10, 20242024/Q49.153B / 12.382B--
Jan 26, 20242024/Q39.446B / 13.000B--

Unlock Free Earnings Estimates

JCR Pharmaceuticals Earnings Reports

  • JCR Pharmaceuticals: Earnings reports for Q1 of March 2025 will be announced in a conference call.

    Jul 30 03:00 ET

  • JCR Pharmaceuticals: 2025 March 1st quarter financial report announcement [Japan standard] (Consolidated)

    Jul 30 03:00 ET

  • JCR Pharmaceuticals: Extraordinary Report

    Jul 23 03:30 ET

  • JCR Pharmaceuticals: Interim report

    Jun 27 20:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 30, 2024

    Buy

    • Strong Buy

      33.33%

    • Buy

      0.00%

    • Hold

      66.67%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg